USPH (US Physical Therapy Inc)
Insider Trading Activity
Every open-market purchase and sale reported by USPH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Eric Joseph Williams | President and COO | F | — | — |
| 2026-08-24 | JASON TRAVIS CURTIS | Interim CFO | F | — | — |
| 2026-08-24 | GRAHAM D. REEVE | COO | F | — | — |
| 2026-08-24 | Richard Binstein | EVP Gen'l Counsel & Secretary | F | — | — |
| 2026-06-22 | JASON TRAVIS CURTIS | Interim CFO | F | — | — |
| 2026-06-22 | GRAHAM D. REEVE | COO | F | — | — |
| 2026-06-10 | Peter Francis Minan | Director | Buy | — | — |
| 2026-05-28 | Peter Francis Minan | Director | A | — | — |
| 2026-05-28 | Bernard A Harris Jr | Director | A | — | — |
| 2026-05-28 | Anne Motsenbocker | Director | A | — | — |
| 2026-05-28 | Regg E. Swanson | Director | A | — | — |
| 2026-05-28 | Kathleen A Gilmartin | Director | A | — | — |
| 2026-05-20 | Kathleen A Gilmartin | Director | A | — | — |
| 2026-05-20 | Peter Francis Minan | Director | A | — | — |
| 2026-05-20 | Anne Motsenbocker | Director | A | — | — |
| 2026-05-20 | Regg E. Swanson | Director | A | — | — |
| 2026-05-20 | Bernard A Harris Jr | Director | A | — | — |
| 2026-03-12 | GRAHAM D. REEVE | COO | Sell | — | — |
| 2026-03-11 | GRAHAM D. REEVE | COO | Sell | — | — |
| 2026-03-10 | CAREY P HENDRICKSON | Chief Financial Officer | D | — | — |
| 2026-03-09 | Richard Binstein | EVP Gen'l Counsel & Secretary | Sell | — | — |
| 2026-02-25 | GRAHAM D. REEVE | COO | A | — | — |
| 2026-02-25 | Eric Joseph Williams | President and COO | A | — | — |
| 2026-02-25 | Richard Binstein | EVP Gen'l Counsel & Secretary | A | — | — |
| 2026-02-25 | CHRISTOPHER J READING | Chairman of the Board and CEO | A | — | — |
| 2026-02-25 | CAREY P HENDRICKSON | Chief Financial Officer | A | — | — |
| 2025-11-25 | GRAHAM D. REEVE | COO | Sell | — | — |
| 2025-11-24 | Kathleen A Gilmartin | Director | Buy | — | — |
| 2025-09-11 | NANCY HAM | Director | Sell | — | — |
| 2025-09-08 | Eric Joseph Williams | President and COO | Sell | — | — |
| 2025-09-05 | CHRISTOPHER J READING | Chairman of the Board and CEO | Sell | — | — |
| 2025-08-25 | CAREY P HENDRICKSON | Chief Financial Officer | Sell | — | — |
| 2025-08-21 | GRAHAM D. REEVE | COO | Sell | — | — |
| 2025-08-19 | Richard Binstein | EVP Gen'l Counsel & Secretary | D | — | — |
| 2025-08-12 | GRAHAM D. REEVE | COO | Sell | — | — |
| 2025-06-13 | NANCY HAM | Director | Sell | — | — |
| 2025-05-22 | GRAHAM D. REEVE | COO | Sell | — | — |
| 2025-05-22 | Eric Joseph Williams | President and COO | Sell | — | — |
| 2025-05-21 | Kathleen A Gilmartin | Director | A | — | — |
| 2025-05-21 | Anne Motsenbocker | Director | A | — | — |
| 2025-05-21 | Regg E. Swanson | Director | A | — | — |
| 2025-05-21 | Clayton Trier | Director | A | — | — |
| 2025-05-21 | Bernard A Harris Jr | Director | A | — | — |
| 2025-05-21 | NANCY HAM | Director | A | — | — |
| 2025-03-18 | CAREY P HENDRICKSON | Chief Financial Officer | G | — | — |
| 2025-03-07 | GRAHAM D. REEVE | COO | Sell | — | — |
| 2025-02-26 | CAREY P HENDRICKSON | Chief Financial Officer | A | — | — |
| 2025-02-26 | CHRISTOPHER J READING | Chairman of the Board and CEO | A | — | — |
| 2025-02-26 | Eric Joseph Williams | President and COO | A | — | — |
| 2025-02-26 | GRAHAM D. REEVE | COO | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 176,700 | — |
| — | Chairman of the Board and CEO | 139,088 | — |
| — | Director | 128,654 | — |
| — | Director | 67,500 | — |
| — | President and COO | 39,617 | — |
| — | Director | 39,349 | — |
| — | COO | 28,554 | — |
| — | Chief Financial Officer | 27,808 | — |
| — | Director | 27,092 | — |
| — | Director | 24,489 | — |
| — | EVP Gen'l Counsel & Secretary | 24,417 | — |
| — | Director | 23,088 | — |
| — | Director | 20,914 | — |
| — | Director | 17,580 | — |
| — | Director | 15,851 | — |
| — | Chief Operating Officer | 13,867 | — |
| — | Director | 10,943 | — |
| — | Director | 9,812 | — |
| — | Chief Financial Officer | 9,082 | — |
| — | Director | 8,306 | — |
| — | Interim CFO | 3,853 | — |
| — | Director | 3,280 | — |
| — | Director | 2,923 | — |
| — | Director | 1,994 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the USPH quote page; the site-wide leaderboard is on the insider transactions hub.